Metabolic syndrome and fatty liver in chronic HBV patients
Part of Digestive system, Hormones & metabolism clinical trials.
This study looks at how common metabolic syndrome and fatty liver disease are in Egyptian patients with chronic hepatitis B (HBV). It aims to understand the link between these conditions and may help guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have chronic hepatitis B (HBV).
- You do NOT have hepatitis C (HCV) or HIV.
- You are willing to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information about metabolic and unexplained (cryptogenic) liver disease and looks at “omics” tests, which are lab tests that measure patterns in blood or tissue to learn what drives the disease. It may help researchers better understand fatty liver and related serious complications, like liver scarring and liver cancer.
This study looks at people with chronic hepatitis B who are also diagnosed with metabolic syndrome (a cluster of issues like belly fat, high blood pressure, abnormal cholesterol, or high blood sugar). It aims to see how these health factors may change how well the first hepatitis B antiviral medication works.
This observational study looks at people with chronic hepatitis B who also have fatty liver (non-alcoholic fatty liver disease). It follows how their liver health changes over time and may help doctors understand outcomes and risk factors.
This study follows adults with chronic hepatitis B who also have fatty liver and tests an exercise approach to see how it affects liver health. You may be followed over time and helped with an exercise plan if you qualify.
This study looks at people with fatty liver disease and common health issues like obesity, diabetes, high blood pressure, or abnormal cholesterol. It may help researchers understand how liver fat and heart/metabolism problems relate and how they affect health over time.
This study looks at how common antiviral resistance is in people with chronic hepatitis B who are taking certain medications. It may help doctors better understand which treatments work best for patients in Egypt.
Hear when a new Metabolic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.